UnitedHealth Group Incorporated vs Zimmer Biomet Holdings, Inc. — Stock Comparison
Q·Score Breakdown
6.3
Neutral
Overall
6.9
Neutral
Quality
Health
Growth
Valuation
Sentiment
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
ZBH
Earnings growing 34% year-over-year on 9% revenue growth.
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
BUY
Target $387.27 (+5.0%)
26 analysts
HOLD
Target $98.52 (+18.8%)
21 analysts
Fundamentals
UNH
ZBH
27.9×
Trailing P/E
21.5×
17.8×
Forward P/E
9.2×
2.7%
Profit Margin
9.1%
18.8%
Gross Margin
70.2%
12.2%
ROE
6.1%
2.0%
Revenue Growth
9.3%
0.7%
Earnings Growth
34.1%
0.41
Beta
0.61
—
Price / Book
—
$334.9B
Market Cap
$16.0B
$235 – $410
52-Week Range
$80 – $108
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →